Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Zanello, Galliano ^a,b   Berri, Mustapha ^b   Dupont, Joëlle ^c   Sizaret, Pierre Yves ^d   D'Inca, Romain ^a   Salmon, Henri ^b   Meurens, François ^b  

^a Lesaffre International   (France)

^b UR1282   (France)

^c UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

^d UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12P35; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROBIOTIC AGENT; CHEMOKINE; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENTEROTOXIGENIC ESCHERICHIA COLI; ENZYME PHOSPHORYLATION; FUNGAL STRAIN; GENE EXPRESSION REGULATION; IMMUNOMODULATION; INFLAMMATION; INTESTINE EPITHELIUM CELL; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; SWINE; UPREGULATION; ANIMAL; ANTIGEN ANTIBODY REACTION; CELL DIFFERENTIATION; CELL LINE; CELL MEMBRANE; COCULTURE; CYTOLOGY; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SECRETION;

ESCHERICHIA COLI; SACCHAROMYCES CEREVISIAE; SUIDAE; SUS;

AGGLUTINATION; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL MEMBRANE; CHEMOKINES; COCULTURE TECHNIQUES; ENTEROTOXIGENIC ESCHERICHIA COLI; GENE EXPRESSION REGULATION; INTERLEUKIN-6; INTERLEUKIN-8; INTESTINAL MUCOSA; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROBIOTICS; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE; SWINE;

EID: 79953680466     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018573     Document Type: Article

References (78)

1. Fairbrother JM, Nadeau E, Gyles CL, (2005) Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Anim Health Res Rev 6: 17-39.
2. Fang L, Gan Z, Marquardt RR, (2000) Isolation, affinity purification, and identification of piglet small intestine mucosa receptor for enterotoxigenic Escherichia coli k88ac+ fimbriae. Infect Immun 68: 564-569.
3. Jin LZ, Zhao X, (2000) Intestinal receptors for adhesive fimbriae of enterotoxigenic Escherichia coli (ETEC) K88 in swine-a review. Appl Microbiol Biotechnol 54: 311-318.
4. Levine MM, (1981) Adhesion of enterotoxigenic Escherichia coli in humans and animals. Ciba Found Symp 80: 142-160.
5. Nagy B, Fekete PZ, (2005) Enterotoxigenic Escherichia coli in veterinary medicine. Int J Med Microbiol 295: 443-454.
6. Sanchez J, Holmgren J, (2005) Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea. Curr Opin Immunol 17: 388-398.
7. Van den Broeck W, Cox E, Goddeeris BM, (1999) Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae. Infect Immun 67: 520-526.
8. Frydendahl K, (2002) Prevalence of serogroups and virulence genes in Escherichia coli associated with postweaning diarrhoea and edema disease in pigs and a comparison of diagnostic approaches. Vet Microbiol 85: 169-182.
9. Docic M, Bilkei G, (2003) Differences in antibiotic resistance in Escherichia coli, isolated from East-European swine herds with or without prophylactic use of antibiotics. J Vet Med B Infect Dis Vet Public Health 50: 27-30.
10. Lanz R, Kuhnert P, Boerlin P, (2003) Antimicrobial resistance and resistance gene determinants in clinical Escherichia coli from different animal species in Switzerland. Vet Microbiol 91: 73-84.
11. Maynard C, Fairbrother JM, Bekal S, Sanschagrin F, Levesque RC, et al. (2003) Antimicrobial resistance genes in enterotoxigenic Escherichia coli O149:K91 isolates obtained over a 23-year period from pigs. Antimicrob Agents Chemother 47: 3214-3221.
12. Zanello G, Meurens F, Berri M, Salmon H, (2009) Saccharomyces boulardii effects on gastrointestinal diseases. Curr Issues Mol Biol 11: 47-58.
13. Wu X, Vallance BA, Boyer L, Bergstrom KS, Walker J, et al. (2008) Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol 294: G295-306.
14. Castagliuolo I, Riegler MF, Valenick L, LaMont JT, Pothoulakis C, (1999) Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun 67: 302-307.
15. Czerucka D, Dahan S, Mograbi B, Rossi B, Rampal P, (2000) Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun 68: 5998-6004.
16. Mumy KL, Chen X, Kelly CP, McCormick BA, (2007) Saccharomyces boulardii interferes with Shigella pathogenesis by post-invasion signaling events. Am J Physiol Gastrointest Liver Physiol.
17. Rodrigues AC, Cara DC, Fretez SH, Cunha FQ, Vieira EC, et al. (2000) Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 89: 404-414.
18. Martins FS, Dalmasso G, Arantes RM, Doye A, Lemichez E, et al. (2010) Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection. PLoS One 5: e8925.
19. Oswald IP, (2006) Role of intestinal epithelial cells in the innate immune defence of the pig intestine. Vet Res 37: 359-368.
20. Chen X, Kokkotou EG, Mustafa N, Bhaskar KR, Sougioultzis S, et al. (2006) Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis. J Biol Chem 281: 24449-24454.
21. Dahan S, Busuttil V, Imbert V, Peyron JF, Rampal P, et al. (2002) Enterohemorrhagic Escherichia coli infection induces interleukin-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappaB and AP-1 in T84 cells. Infect Immun 70: 2304-2310.
22. Dahan S, Dalmasso G, Imbert V, Peyron JF, Rampal P, et al. (2003) Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect Immun 71: 766-773.
23. Dalmasso G, Loubat A, Dahan S, Calle G, Rampal P, et al. (2006) Saccharomyces boulardii prevents TNF-alpha-induced apoptosis in EHEC-infected T84 cells. Res Microbiol 157: 456-465.
24. Kagnoff MF, Eckmann L, (1997) Epithelial cells as sensors for microbial infection. J Clin Invest 100: 6-10.
25. Berkes J, Viswanathan VK, Savkovic SD, Hecht G, (2003) Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52: 439-451.
26. Edwards-Ingram L, Gitsham P, Burton N, Warhurst G, Clarke I, et al. (2007) Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae. Appl Environ Microbiol 73: 2458-2467.
27. Fietto JL, Araujo RS, Valadao FN, Fietto LG, Brandao RL, et al. (2004) Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can J Microbiol 50: 615-621.
28. Hennequin C, Thierry A, Richard GF, Lecointre G, Nguyen HV, et al. (2001) Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains. J Clin Microbiol 39: 551-559.
29. Jurgens MH, Rikabi RA, Zimmerman DR, (1997) The effect of dietary active dry yeast supplement on performance of sows during gestation-lactation and their pigs. J Anim Sci 75: 593-597.
30. Perez-Sotelo LS, Talavera-Rojas M, Monroy-Salazar HG, Lagunas-Bernabe S, Cuaron-Ibarguengoytia JA, et al. (2005) In vitro evaluation of the binding capacity of Saccharomyces cerevisiae Sc47 to adhere to the wall of Salmonella spp. Rev Latinoam Microbiol 47: 70-75.
31. Foligne B, Dewulf J, Vandekerckove P, Pignede G, Pot B, (2010) Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice. World J Gastroenterol 16: 2134-2145.
32. Desreumaux P, Neut C, Cazaubiel M, Pichelin M, Pelerin F, Justen P, (2010) Saccharomyces cerevisiae CNCM I-3856 reduces digestive discomfort and abdominal pain in subjects with irritable bowel syndrome: a randomized double-blinded placebo-controlled clinical trial. Barcelona, Spain 18th United European Gastroenterology Week.
33. Etienne-Mesmin L, Livrelli V, Privat M, Denis S, Cardot JM, et al. (2010) Effect of a new probiotic Saccharomyces cerevisiae strain on the survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model. Appl Environ Microbiol.
34. Koh SY, George S, Brozel V, Moxley R, Francis D, et al. (2008) Porcine intestinal epithelial cell lines as a new in vitro model for studying adherence and pathogenesis of enterotoxigenic Escherichia coli. Vet Microbiol 130: 191-197.
35. Roselli M, Finamore A, Britti MS, Konstantinov SR, Smidt H, et al. (2007) The novel porcine Lactobacillus sobrius strain protects intestinal cells from enterotoxigenic Escherichia coli K88 infection and prevents membrane barrier damage. J Nutr 137: 2709-2716.
36. van der Aa Kuhle A, Skovgaard K, Jespersen L, (2005) In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains. Int J Food Microbiol 101: 29-39.
37. Devriendt B, Stuyven E, Verdonck F, Goddeeris BM, Cox E, (2010) Enterotoxigenic Escherichia coli (K88) induce proinflammatory responses in porcine intestinal epithelial cells. Dev Comp Immunol 34: 1175-1182.
38. Konstantinov SR, Smidt H, Akkermans AD, Casini L, Trevisi P, et al. (2008) Feeding of Lactobacillus sobrius reduces Escherichia coli F4 levels in the gut and promotes growth of infected piglets. FEMS Microbiol Ecol 66: 599-607.
39. Lessard M, Dupuis M, Gagnon N, Nadeau E, Matte JJ, et al. (2009) Administration of Pediococcus acidilactici or Saccharomyces cerevisiae boulardii modulates development of porcine mucosal immunity and reduces intestinal bacterial translocation after Escherichia coli challenge. J Anim Sci 87: 922-934.
40. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, et al. (2000) Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 164: 966-972.
41. Tallant T, Deb A, Kar N, Lupica J, de Veer MJ, et al. (2004) Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells. BMC Microbiol 4: 33.
42. Chow AW, Liang JF, Wong JS, Fu Y, Tang NL, et al. (2010) Polarized secretion of interleukin (IL)-6 and IL-8 by human airway epithelia 16HBE14o- cells in response to cationic polypeptide challenge. PLoS One 5: e12091.
43. Fahey JV, Schaefer TM, Channon JY, Wira CR, (2005) Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Hum Reprod 20: 1439-1446.
44. Jurczyluk J, Brown D, Stanley KK, (2003) Polarised secretion of cytokines in primary human microvascular endothelial cells is not dependent on N-linked glycosylation. Cell Biol Int 27: 997-1003.
45. Sougioultzis S, Simeonidis S, Bhaskar KR, Chen X, Anton PM, et al. (2006) Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun 343: 69-76.
46. Zanello G, Meurens F, Berri M, Chevaleyre C, Melo S, et al. Saccharomyces cerevisiae decreases inflammatory responses induced by F4+ enterotoxigenic Escherichia coli in porcine intestinal epithelial cells. Vet Immunol Immunopathol (In press).
47. Cekic C, Casella CR, Eaves CA, Matsuzawa A, Ichijo H, et al. (2009) Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A. J Biol Chem 284: 31982-31991.
48. Dommisch H, Chung WO, Jepsen S, Hacker BM, Dale BA, (2010) Phospholipase C, p38/MAPK, and NF-kappaB-mediated induction of MIP-3alpha/CCL20 by Porphyromonas gingivalis. Innate Immun 16: 226-234.
49. Huang FC, (2009) Upregulation of Salmonella-induced IL-6 production in Caco-2 cells by PJ-34, PARP-1 inhibitor: involvement of PI3K, p38 MAPK, ERK, JNK, and NF-kappaB. Mediators Inflamm 2009: 103890.
50. Valledor AF, Sanchez-Tillo E, Arpa L, Park JM, Caelles C, et al. (2008) Selective roles of MAPKs during the macrophage response to IFN-gamma. J Immunol 180: 4523-4529.
51. Bandyopadhaya A, Bhowmick S, Chaudhuri K, (2009) Activation of proinflammatory response in human intestinal epithelial cells following Vibrio cholerae infection through PI3K/Akt pathway. Can J Microbiol 55: 1310-1318.
52. Scharl M, Paul G, Barrett KE, McCole DF, (2009) AMP-activated protein kinase mediates the interferon-gamma-induced decrease in intestinal epithelial barrier function. J Biol Chem 284: 27952-27963.
53. Chen X, Fruehauf J, Goldsmith JD, Xu H, Katchar KK, et al. (2009) Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice. Gastroenterology 137: 914-923.
54. Kunkel EJ, Campbell JJ, Haraldsen G, Pan J, Boisvert J, et al. (2000) Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med 192: 761-768.
55. Meurens F, Berri M, Whale J, Dybvig T, Strom S, et al. (2006) Expression of TECK/CCL25 and MEC/CCL28 chemokines and their respective receptors CCR9 and CCR10 in porcine mucosal tissues. Vet Immunol Immunopathol 113: 313-327.
56. Qamar A, Aboudola S, Warny M, Michetti P, Pothoulakis C, et al. (2001) Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect Immun 69: 2762-2765.
57. Ericsson A, Kotarsky K, Svensson M, Sigvardsson M, Agace W, (2006) Functional characterization of the CCL25 promoter in small intestinal epithelial cells suggests a regulatory role for caudal-related homeobox (Cdx) transcription factors. J Immunol 176: 3642-3651.
58. Meurens F, Berri M, Siggers RH, Willing BP, Salmon H, et al. (2007) Commensal bacteria and expression of two major intestinal chemokines, TECK/CCL25 and MEC/CCL28, and their receptors. PLoS One 2: e677.
59. Rizzetto L, Kuka M, De Filippo C, Cambi A, Netea MG, et al. (2010) Differential IL-17 production and mannan recognition contribute to fungal pathogenicity and commensalism. J Immunol 184: 4258-4268.
60. Saegusa S, Totsuka M, Kaminogawa S, Hosoi T, (2009) Saccharomyces cerevisiae and Candida albicans stimulate cytokine secretion from human neutrophil-like HL-60 cells differentiated with retinoic acid or dimethylsulfoxide. Biosci Biotechnol Biochem 73: 2600-2608.
61. Bridger PS, Mohr M, Stamm I, Frohlich J, Follmann W, et al. (2010) Primary bovine colonic cells: a model to study strain-specific responses to Escherichia coli. Vet Immunol Immunopathol 137: 54-63.
62. Escher P, Braissant O, Basu-Modak S, Michalik L, Wahli W, et al. (2001) Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 142: 4195-4202.
63. Mansen A, Guardiola-Diaz H, Rafter J, Branting C, Gustafsson JA, (1996) Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa. Biochem Biophys Res Commun 222: 844-851.
64. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, et al. (1999) A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 104: 383-389.
65. Lee SK, Kim HJ, Chi SG, Jang JY, Nam KD, et al. (2005) [Saccharomyces boulardii activates expression of peroxisome proliferator-activated receptor-gamma in HT-29 cells]. Korean J Gastroenterol 45: 328-334.
66. Adachi M, Kurotani R, Morimura K, Shah Y, Sanford M, et al. (2006) Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut 55: 1104-1113.
67. Kaplan JM, Hake PW, Denenberg A, Nowell M, Piraino G, et al. (2010) Phosphorylation of Extracellular Signal-Regulated Kinase (ERK)-1/2 Is Associated with the Downregulation of Peroxisome Proliferator-Activated Receptor (PPAR)-gamma during Polymicrobial Sepsis. Mol Med 16: 491-497.
68. Zhou Y, Jia X, Wang G, Wang X, Liu J, (2009) PI-3 K/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARgamma gene expression in primary rat hepatic stellate cells. Mol Cell Biochem 325: 131-139.
69. Wei-guo Z, Hui Y, Shan L, Yun Z, Wen-cheng N, et al. (2009) PPAR-gamma agonist inhibits Ang II-induced activation of dendritic cells via the MAPK and NF-kappaB pathways. Immunol Cell Biol 88: 305-312.
70. Johnson AM, Kaushik RS, Hardwidge PR, (2009) Disruption of transepithelial resistance by enterotoxigenic Escherichia coli. Vet Microbiol.
71. Roselli M, Britti MS, Le Huerou-Luron I, Marfaing H, Zhu WY, et al. (2007) Effect of different plant extracts and natural substances (PENS) against membrane damage induced by enterotoxigenic Escherichia coli K88 in pig intestinal cells. Toxicol In Vitro 21: 224-229.
72. Moeser AJ, Nighot PK, Roerig B, Ueno R, Blikslager AT, (2008) Comparison of the chloride channel activator lubiprostone and the oral laxative Polyethylene Glycol 3350 on mucosal barrier repair in ischemic-injured porcine intestine. World J Gastroenterol 14: 6012-6017.
73. Nighot PK, Moeser AJ, Ryan KA, Ghashghaei T, Blikslager AT, (2009) ClC-2 is required for rapid restoration of epithelial tight junctions in ischemic-injured murine jejunum. Exp Cell Res 315: 110-118.
74. Gonzalez-Vallina R, Wang H, Zhan R, Berschneider HM, Lee RM, et al. (1996) Lipoprotein and apolipoprotein secretion by a newborn piglet intestinal cell line (IPEC-1). Am J Physiol 271: G249-259.
75. Nygard AB, Jorgensen CB, Cirera S, Fredholm M, (2007) Selection of reference genes for gene expression studies in pig tissues using SYBR green qPCR. BMC Mol Biol 8: 67.
76. Bruel T, Guibon R, Melo S, Guillen N, Salmon H, et al. (2010) Epithelial induction of porcine suppressor of cytokine signaling 2 (SOCS2) gene expression in response to Entamoeba histolytica. Dev Comp Immunol 34: 562-571.
77. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
78. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622.